The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression

Journal of Psychiatric Research

Volumn 53, Issue 1, 2014, Pages 47-53

  Okada, Satoshi ^a   Morinobu, Shigeru ^a,e   Fuchikami, Manabu ^a   Segawa, Masahiro ^a   Yokomaku, Kana ^a   Kataoka, Tsutomu ^a   Okamoto, Yasumasa ^a   Yamawaki, Shigeto ^a   Inoue, Takeshi ^b   Kusumi, Ichiro ^b   Koyama, Tsukasa ^b   Tsuchiyama, Kounosuke ^c   Terao, Takeshi ^c   Kokubo, Yosuke ^d   Mimura, Masaru ^d,f  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OITA UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KOCHI UNIVERSITY   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antidepressant; DNA methylation; Major depression; Serotonin transporter; Serotonin transporter linked polymorphic region; Therapeutic response

Indexed keywords

FLUVOXAMINE; GENOMIC DNA; MILNACIPRAN; PAROXETINE; SEROTONIN TRANSPORTER; ANTIDEPRESSANT AGENT; SLC6A4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; EARLY TRAUMA INVENTORY; FEMALE; FOLLOW UP; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG ADULT; CASE CONTROL STUDY; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; GENETICS; PHARMACOGENETICS; PSYCHOLOGICAL RATING SCALE; STATISTICS;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CPG ISLANDS; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHARMACOGENETICS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATISTICS AS TOPIC;

EID: 84897418403     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.02.002     Document Type: Article

References (47)

1. Beach S.R., Brody G.H., Todorov A.A., Gunter T.D., Philibert R.A. Methylation at SLC6A4 is linked to family history of child abuse: an examination of the Iowa adoptee sample. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:710-713.
2. Beach S.R., Brody G.H., Todorov A.A., Gunter T.D., Philibert R.A. Methylation at 5HTT mediates the impact of child sex abuse on women's antisocial behavior: an examination of the Iowa adoptee sample. Psychosom Med 2011, 73:83-87.
3. Bell J.T., Pai A.A., Pickrell J.K., Gaffney D.J., Pique-Regi R., Degner J.F., et al. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol 2011, 12:R10.
4. Bradley S.L., Dodelzon K., Sandhu H.K., Philibert R.A. Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005, 136B:58-61.
5. Bremner J.D., Bolus R., Mayer E.A. Psychometric properties of the early trauma inventory-self report. JNerv Ment Dis 2007, 195(3):211-218. 10.1097/01.nmd.0000243824.84651.6c.
6. Bremner J.D., Vermetten E., Mazure C.M. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the early trauma inventory. Depress Anxiety 2000, 12(1):1-12.
7. Cannon D.M., Ichise M., Rollis D., Klaver J.M., Gandhi S.K., Charney D.S., et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 2007, 62:870-877.
8. Carroll B.J. The dexamethasone suppression test for melancholia. Br J Psychiatry 1982, 140:292-304.
9. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. Aspecific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981, 38:15-22.
10. Cusin C., yang H., Albert Y., Fava M. Rating scales for depression. Handbook of clinical rating scales and assessment in psychiatry and mental health 2009, Humana Press, a Part of Springer Science Business Media. doi:10.1007/978-1-59745-387-5_2, L. Baer, M.A. Blais (Eds.).
11. D'Addario C., Dell'Osso B., Galimberti D., Palazzo M.C., Benatti B., Di Francesco A., et al. Epigenetic modulation of BDNF gene in patients with major depressive disorder. Biol Psychiatry 2013, 73:e6-7.
12. Dimas A.S., Deutsch S., Stranger B.E., Montgomery S.B., Borel C., Attar-Cohen H., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250.
13. Duarte J.D. Epigenetics primer: why the clinician should care about epigenetics. Pharmacotherapy 2013, 10.1002/phar. 1325.
14. Feil R., Fraga M.F. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 2011, 13:97-109.
15. Fu Q., Heath A.C., Bucholz K.K., Nelson E., Goldberg J., Lyons M.J., et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry 2002, 59:1125-1132.
16. Fuchikami M., Morinobu S., Segawa M., Okamoto Y., Yamawaki S., Ozaki N., et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 2011, 6:e23881.
17. Goodwin F.K., Jamison K.R. Manic-depressive illness: bipolar disorders and recurrent depression 2007, Oxford Universiy Press. 2nd ed.
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6(4):278-296. 10.1111/j.2044-8260.1967.tb00530.x.
19. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. JPsychiatr Res 1994, 28:341-356.
20. Kang H.J., Kim J.M., Stewart R., Kim S.Y., Bae K.Y., Kim S.W., et al. Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry 2013, 44:23-28.
21. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011, 68:444-454.
22. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
23. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1062-1073.
24. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
25. McGuffin P., Katz R., Watkins S., Rutherford J. Ahospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry 1996, 53:129-136.
26. Mill J., Heijmans B.T. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 2013, 14:585-594.
27. Moldin S.O., Gottesman I.I. At issue: genes, experience, and chance in schizophrenia - positioning for the 21st century. Schizophr Bull 1997, 23:547-561.
28. Mossner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A.C., Muller N., et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 2007, 8:141-174.
29. Murphy D.L., Fox M.A., Timpano K.R., Moya P.R., Ren-Patterson R., Andrews A.M., et al. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 2008, 55(6):932-960. 10.1016/j.neuropharm.2008.08.034.
30. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
31. Olsson C.A., Foley D.L., Parkinson-Bates M., Byrnes G., McKenzie M., Patton G.C., et al. Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol Psychol 2010, 83:159-165.
32. Ouellet-Morin I., Wong C.C., Danese A., Pariante C.M., Papadopoulos A.S., Mill J., et al. Increased serotonin transporter gene (SERT) DNA methylation is associated with bullying victimization and blunted cortisol response to stress in childhood: a longitudinal study of discordant monozygotic twins. Psychol Med 2013, 43:1813-1823.
33. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006, 163:52-58.
34. Philibert R., Madan A., Andersen A., Cadoret R., Packer H., Sandhu H. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:101-105.
35. Serretti A., Kato M., De Ronchi D., Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007, 12:247-257.
36. Soto-Ramirez N., Arshad S.H., Holloway J.W., Zhang H., Schauberger E., Ewart S., et al. The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin Epigenetics 2013, 5:1.
37. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. JPsychiatr Res 2003, 37:357-373.
38. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., et al. Population genomics of human gene expression. Nat Genet 2007, 39:1217-1224.
39. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552-1562.
40. Tunnard C., Rane L.J., Wooderson S.C., Markopoulou K., Poon L., Fekadu A., et al. The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression. JAffect Disord 2013.
41. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005, 5:223-231.
42. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012, 380:2163-2196.
43. Wang D., Szyf M., Benkelfat C., Provencal N., Turecki G., Caramaschi D., et al. Peripheral SLC6A4 DNA methylation is associated with invivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One 2012, 7:e39501.
44. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-854.
45. World Health Organization (WHO) Depression 2012, Media Centre, [accessed 15.03.13]. http://www.who.int/mediacentre/factsheets/fs269/en/.
46. Widom C.S., DuMont K., Czaja S.J. Aprospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 2007, 64:49-56.
47. Zhang T.Y., Labonte B., Wen X.L., Turecki G., Meaney M.J. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology 2013, 38:111-123.